EMG
ZYNE

ETF Managers Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

ETF Managers Group’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$311K Sell
723,151
-787,721
-52% -$415K 0.01% 531
2022
Q4 		$801K Sell
1,510,872
-748,098
-33% -$474K 0.04% 189
2022
Q3 		$1.65M Sell
2,258,970
-188,437
-8% -$214K 0.05% 165
2022
Q2 		$2.81M Sell
2,447,407
-1,214,935
-33% -$1.55M 0.08% 145
2022
Q1 		$7.87M Sell
3,662,342
-923,399
-20% -$2.2M 0.16% 124
2021
Q4 		$13.3M Buy
4,585,741
+121,967
+3% +$451K 0.26% 110
2021
Q3 		$18.7M Sell
4,463,774
-115,506
-3% -$515K 0.35% 89
2021
Q2 		$24.8M Buy
4,579,280
+2,591,494
+130% +$12.5M 0.4% 86
2021
Q1 		$9.24M Buy
1,987,786
+173,458
+10% +$786K 0.16% 126
2020
Q4 		$5.99M Buy
1,814,328
+923,303
+104% +$3.51M 0.13% 120
2020
Q3 		$2.95M Sell
891,025
-350,571
-28% -$1.29M 0.09% 136
2020
Q2 		$4.18M Buy
1,241,596
+33,470
+3% +$158K 0.15% 109
2020
Q1 		$4.63M Sell
1,208,126
-828,404
-41% -$3.85M 0.21% 94
2019
Q4 		$12.3M Sell
2,036,530
-642,927
-24% -$4.4M 0.43% 83
2019
Q3 		$20.3M Buy
2,679,457
+441,614
+20% +$4.98M 0.73% 45
2019
Q2 		$30.3M Buy
+2,237,843
New +$25.8M 0.97% 40

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ETF Managers Group's ZYNE Position: Q1 2023 in Review

ETF Managers Group reduced its Zynerba Pharmaceuticals, Inc (ZYNE) stake by 52% in Q1 2023, selling an estimated $415K and leaving 723,151 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #531.

ETF Managers Group first reported a position in ZYNE in Q2 2019 and has held it in 16 quarters since. The position peaked at $30.3M in Q2 2019. 44 funds tracked by Wall St. Rank hold ZYNE as of Q1 2023.

  • ETF Managers Group held 723,151 shares of Zynerba Pharmaceuticals, Inc worth $311K as of Q1 2023.
  • ETF Managers Group sold 787,721 Zynerba Pharmaceuticals, Inc shares in Q1 2023, an estimated $415K.
  • Zynerba Pharmaceuticals, Inc made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #531 holding.
  • ETF Managers Group first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2019 and has held it in 16 quarters since.
  • ETF Managers Group's Zynerba Pharmaceuticals, Inc position peaked at $30.3M in Q2 2019.
  • 44 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.